Browsing Tag
Mads Krogsgaard Thomsen
3 posts
Novo Nordisk secures FDA approval for Saxenda label update targeting adolescent obesity treatment
Novo Nordisk, a global leader in diabetes and obesity care, has received approval from the US Food and…
December 6, 2020
Novo Nordisk’s $1.8bn acquisition of Emisphere Technologies: What it means for the future of oral biologics
Danish pharmaceutical giant Novo Nordisk has reached a significant milestone in the development of oral biologic therapies, agreeing…
November 6, 2020
Novo Nordisk to acquire cardio-renal disease company Corvidia Therapeutics
Novo Nordisk acquisition of Corvidia : Danish pharma company Novo Nordisk has agreed to acquire Corvidia Therapeutics from…
June 14, 2020